Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Dummer, R; Schadendorf, D; Nathan, P; Tawbi, H; Robert, C; Ascierto, PA; Ribas, A; Lebbe, C; Mandala, M; Yamazaki, N; Richtig, E; Miller, WH; Gasal, E; Kaper, M; Brase, JC; Mookerjee, B; Long, GV.
The anti-PD-1 antibody spartalizumab (PDR001) in combination with dabrafenib and trametinib in previously untreated patients with advanced BRAF V600-mutant melanoma: First efficacy, safety, and biomarker findings from the part 2 biomarker cohort of COMBi-i
CANCER RES. 2018; 78(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 14-18, 2018; Chicago, IL.
Doi: 10.1158/1538-7445.AM2018-CT182
[Oral Communication]
Web of Science
FullText
FullText_MUG
- Autor*innen der Med Uni Graz:
- Richtig Erika
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):